LIFE LENGTH INITIATES COVID-19 DIAGNOSIS

8 April 2020 Leave your Thoughts

Madrid, April 13, 2020

 

Life Length, a licensed clinical analysis company, has refocused its activity and is already offering the COVID-19 diagnostic test.

Life Length has made a partnership with seven other Spanish companies to form the COVID-19 Alliance (www.alianzacovid19.es), led by Arquimea Group, which already offers the PCR diagnostic service to detect the SARS-CoV-2 virus. The test is offered in the entire Spain with a daily capacity of 10,000 tests.

During the last weeks, Life Length, in coordination with la Fundación Parque Científico de Madrid (FPCM) and in collaboration with other companies, has developed the protocols to carry out this service and help fighting the current health crisis situation.

Life Length, based in Madrid, is a technology platform that thanks to the support of important shareholders including the Fundación Botín and Grupo Alter, has managed to position itself as the world leader in telomere measurement.

The COVID-19 Alliance includes other laboratories and research centers with extensive experience in PCR diagnostics such as CIC BioGUNE, BioAssays, Epidisease, WorldPathol, Cidaut and LabGenetics.

The service includes the shipment of sample collection kits, processing and the results report, all this in just 24 hours. The test detects viral load in both asymptomatic and symptomatic people, with the sensitivity and specificity of the PCR technique that guarantees 99.9% reliability of the results.

More information at www.lifelength.com. To request the PCR test service please visit: www.alianzacovid19.es.

 

*The FPCM offers offices, laboratories and professional services to innovative scientific and technological entities and companies, as well as Genomics scientific services to research groups, hospitals and companies at national and international level.

Facebook
Twitter

Leave a Reply

Your email address will not be published. Required fields are marked *